Coffee drinking and hepatocellular carcinoma: An update

Hepatology

Volumn 50, Issue 4, 2009, Pages 1317-1318

  Bravi, Francesca ^a,b   Bosetti, Cristina ^a   Tavani, Alessandra ^a   La Vecchia, Carlo ^a,b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CASE CONTROL STUDY; CAUSE OF DEATH; COFFEE; COHORT ANALYSIS; CONFIDENCE INTERVAL; DATA ANALYSIS; DRINKING BEHAVIOR; FOOD INTAKE; HEPATITIS B; HEPATITIS C; HUMAN; LETTER; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLICATION; RISK ASSESSMENT; RISK REDUCTION; SOUTHERN EUROPE; VACCINATION; VIRUS TRANSMISSION; CHEMICALLY INDUCED DISORDER; LIVER TUMOR; NOTE;

ALCOHOL DRINKING; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; COFFEE; COHORT STUDIES; HUMANS; LIVER NEOPLASMS;

EID: 70350061697     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.23272     Document Type: Letter

References (9)

1. Bravi F, Bosetti C, Tavani A, Bagnardi V, Gallus S, Negri E, et al. Coffee drinking and hepatocellular carcinoma risk: a meta-analysis. HEPATOLOGY 2007;46:430-435.
2. Wakai K, Kurozawa Y, Shibata A, Fujita Y, Kotani K, Ogimoto I, et al. Liver cancer risk, coffee, and hepatitis C virus infection: a nested case-control study in Japan. Br J Cancer 2007;97:426-428.
3. Hu G, Tuomilehto J, Pukkala E, Hakulinen T, Antikainen R, Vartiainen E, et al. Joint effects of coffee consumption and serum gamma-glutamyltransferase on the risk of liver cancer. HEPATOLOGY 2008;48:129-136.
4. Ohishi W, Fujiwara S, Cologne JB, Suzuki G, Akahoshi M, Nishi N, et al. Risk factors for hepatocellular carcinoma in a Japanese population: a nested case-control study. Cancer Epidemiol Biomarkers Prev 2008;17:846-854.
5. Inoue M, Kurahashi N, Iwasaki M, Shimazu T, Tanaka Y, Mizokami M, et al. Effect of coffee and green tea consumption on the risk of liver cancer: cohort analysis by hepatitis virus infection status. Cancer Epidemiol Biomarkers Prev 2009;18:1746-1753.
6. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 1987;9:1-30.
7. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188.
8. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
9. La Vecchia C. Cancer and liver cancer prevention: is it a fact or just a potential? HEPATOLOGY 2008;48:7-9.